drugset / Trial / NCT02848170
Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension
RandomizedCrossoverOpen-labelTreatment
Summary
Phase 3 study to examine the relation between antihypertensive effect and baseline factors exploratively, compared to olmesartan medoxomil in patients with essential hypertension.
Timeline
- Start
- 2016-08
- Primary completion
- 2017-04
- Completion
- 2017-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CS-3150 | Unknown | 2.5 mg | Oral |
| Comparator | Olmesartan medoxomil | Unknown | 10 mg | Oral |